FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack

Clinical trial NCT06497374 · UNKNOWN

Trial details

NCT number: NCT06497374
Sponsor: Tianjin Medical University General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Neuromyelitis Optica Neuromyelitis Optica Spectrum Disorder NMO Spectrum Disorder

Start date: 2024-07-05
Primary completion: 2025-12-31
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.